Literature DB >> 30882859

Low Plasma Oxytocin Levels and Increased Psychopathology in Hypopituitary Men With Diabetes Insipidus.

Anna Aulinas1, Franziska Plessow1, Elisa Asanza1, Lisseth Silva1, Dean A Marengi1, WuQiang Fan1, Parisa Abedi1, Joseph Verbalis2, Nicholas A Tritos1, Lisa Nachtigall1, Alexander T Faje1, Karen K Miller1, Elizabeth A Lawson1.   

Abstract

CONTEXT: Oxytocin (OT) and vasopressin share anatomical pathways of synthesis and secretion, and patients with central diabetes insipidus (CDI) presumably are at risk for OT deficiency. However, an OT-deficient state in hypopituitary patients has not been established.
OBJECTIVES: We hypothesized that men with CDI compared to patients with similar anterior pituitary deficiencies (APD) but no CDI and healthy controls (HC) of similar age and body mass index, would have lower plasma OT levels, associated with increased psychopathology.
DESIGN: Cross-sectional.
SETTING: Clinical research center. PARTICIPANTS: Sixty-two men (20 CDI, 20 APD, 22 HC), age 18 to 60 years.
INTERVENTIONS: Frequent sampling of blood every 5 minutes for OT over 1 hour and validated questionnaires to assess psychopathology. MAIN OUTCOMES: Pooled plasma OT levels; depressive, anxiety, and alexithymia symptoms; and quality of life.
RESULTS: The mean 1-hour pool of fasting OT levels was lower in CDI compared with APD and HC (P = 0.02 and P = 0.009, respectively), with no differences between APD and HC (P = 0.78). Symptoms of depression, anxiety, and alexithymia were more pronounced in CDI than in HC (P = 0.001, P = 0.004, and P = 0.02, respectively). Although CDI and APD reported worse physical health compared with HC (P = 0.001 and P = 0.005) with no differences between APD and CDI, only CDI reported worse mental health compared with HC (P = 0.009).
CONCLUSIONS: We have demonstrated low plasma OT levels and increased psychopathology in hypopituitary men with CDI, suggestive of a possible OT-deficient state. Larger studies of both sexes are required to confirm these findings and clinically characterize hypopituitary patients with OT deficiency.
Copyright © 2019 Endocrine Society.

Entities:  

Year:  2019        PMID: 30882859      PMCID: PMC6570634          DOI: 10.1210/jc.2018-02608

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  58 in total

1.  A critical evaluation of simple methods for the estimation of free testosterone in serum.

Authors:  A Vermeulen; L Verdonck; J M Kaufman
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

Review 2.  The oxytocin receptor system: structure, function, and regulation.

Authors:  G Gimpl; F Fahrenholz
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  A longitudinal SEM approach to STAI data:two comprehensive multitrait-multistate models.

Authors:  Stephané Vautier
Journal:  J Pers Assess       Date:  2004-10

4.  Cost of illness in adult patients with hypopituitarism.

Authors:  C Ehrnborg; L Hakkaart-Van Roijen; B Jonsson; F F Rutten; B A Bengtsson; T Rosén
Journal:  Pharmacoeconomics       Date:  2000-06       Impact factor: 4.981

5.  The burden of illness of hypopituitary adults with growth hormone deficiency.

Authors:  L Hakkaart-van Roijen; A Beckers; A Stevenaert; F F Rutten
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

6.  Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

Authors:  Guy Griebel; Jacques Simiand; Claudine Serradeil-Le Gal; Jean Wagnon; Marc Pascal; Bernard Scatton; Jean-Pierre Maffrand; Philippe Soubrie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

7.  High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease.

Authors:  Birgitta Bülow; Lars Hagmar; Palle Ørbaek; Kai Osterberg; Eva Marie Erfurth
Journal:  Clin Endocrinol (Oxf)       Date:  2002-02       Impact factor: 3.478

8.  Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain.

Authors:  M Regal; C Páramo; S M Sierra; R V Garcia-Mayor
Journal:  Clin Endocrinol (Oxf)       Date:  2001-12       Impact factor: 3.478

9.  Hypoglycemia-induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood-brain barrier.

Authors:  P Chiodera; R Volpi; L Capretti; G Speroni; A Marcato; G Rossi; V Coiro
Journal:  Neuroendocrinology       Date:  1992-06       Impact factor: 4.914

10.  Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415.

Authors:  Jeanne Stemmelin; Ludovit Lukovic; Nicolas Salome; Guy Griebel
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

View more
  10 in total

1.  Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men.

Authors:  Anna Aulinas; Francisco J Guarda; Elaine W Yu; Melanie S Haines; Elisa Asanza; Lisseth Silva; Nicholas A Tritos; Joseph Verbalis; Karen K Miller; Elizabeth A Lawson
Journal:  Neuroendocrinology       Date:  2020-02-20       Impact factor: 4.914

Review 2.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

Review 3.  Diagnosis and Management of Central Diabetes Insipidus in Adults.

Authors:  Maria Tomkins; Sarah Lawless; Julie Martin-Grace; Mark Sherlock; Chris J Thompson
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

Review 4.  Advances in human oxytocin measurement: challenges and proposed solutions.

Authors:  Benjamin A Tabak; Gareth Leng; Angela Szeto; Karen J Parker; Joseph G Verbalis; Toni E Ziegler; Mary R Lee; Inga D Neumann; Armando J Mendez
Journal:  Mol Psychiatry       Date:  2022-08-23       Impact factor: 13.437

Review 5.  Insights into non-classic and emerging causes of hypopituitarism.

Authors:  Flavia Prodam; Marina Caputo; Chiara Mele; Paolo Marzullo; Gianluca Aimaretti
Journal:  Nat Rev Endocrinol       Date:  2020-11-27       Impact factor: 43.330

Review 6.  Metabolic Effects of Oxytocin.

Authors:  Shana E McCormack; James E Blevins; Elizabeth A Lawson
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

7.  Ameliorative Effect of Oxytocin on FBN1 and PEPCK Gene Expression, and Behavioral Patterns in Rats' Obesity-Induced Diabetes.

Authors:  Asmaa Elnagar; Khalifa El-Dawy; Hussein I El-Belbasi; Ibrahim F Rehan; Hamdy Embark; Zeinab Al-Amgad; Obeid Shanab; Elsayed Mickdam; Gaber E Batiha; Salman Alamery; Samer S Fouad; Simona Cavalu; Mohammed Youssef
Journal:  Front Public Health       Date:  2022-04-07

8.  Robust Reductions of Body Weight and Food Intake by an Oxytocin Analog in Rats.

Authors:  Clinton T Elfers; James E Blevins; Elizabeth A Lawson; Richard Pittner; David Silva; Alex Kiselyov; Christian L Roth
Journal:  Front Physiol       Date:  2021-09-27       Impact factor: 4.566

9.  Oxytocin levels in response to pituitary provocation tests in healthy volunteers.

Authors:  Clara O Sailer; Bettina Winzeler; Sandrine A Urwyler; Ingeborg Schnyder; Julie Refardt; Anne Eckert; Nimmy Varghese; Martin Fassnacht; Irina Chifu; Elizabeth A Lawson; Joseph G Verbalis; Wiebke Fenske; Mirjam Christ-Crain
Journal:  Eur J Endocrinol       Date:  2021-08-03       Impact factor: 6.558

Review 10.  The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans.

Authors:  Liya Kerem; Elizabeth A Lawson
Journal:  Int J Mol Sci       Date:  2021-07-20       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.